Skip to main content
Home
  • About Mainstay
  • About Reactiv8
  • For Clinicians
  • Home
  • Investors
  • News & Events
  • Careers
  • Contact Us
  • EN
  • FR
  • DE
  • NL
  • US
  • AU
Sub menu▸
  • OVERVIEW
  • Results and Presentations
  • News
  • Governance
    • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Board Committees
    • AGM
    • Documents relating to proposed delisting transaction and related shareholder meetings on 8 May
    • Documents relating to February 2021 EGM
  • Shareholder Information
  • Contact Us

Documents relating to February 2021 EGM

Date
Title
  • 09 Feb 2021
    Results of Voting at 9 February 2021 Extraordinary General Meeting
  • 15 Jan 2021
    Mainstay Medical Holdings plc - Notice of Extraordinary General Meeting
  • 15 Jan 2021
    Redline showing changes against current Mainstay Medical Holdings constitution

© Copyright 2020 Mainstay Medical Limited. All rights reserved.

Footer menu

  • Site Map
  • Contact Us
  • Impressum
  • Privacy Policy
  • Terms & Conditions
  • Commercial Terms & Conditions

ReActiv8 is CE marked for the treatment of chronic low back pain and available for sale in Europe.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show